DistantNews
Support us
๐Ÿ‡ณ๐Ÿ‡ฌ Nigeria /Health & Science

Harvard Varsity Lauds Nigeria's New Malaria Diagnostic Factory

From ThisDay · () English

Translated from English, summarized and contextualized by DistantNews.

At a glance

News Named sources New plan
  • A new factory for producing rapid diagnostic tests (RDTs) and in-vitro diagnostic (IVD) products has been established in Nigeria.
  • The facility, a partnership between NASENI and Troment Nigeria Limited, aims to locally manufacture diagnostic kits for diseases like malaria, HIV, and COVID-19, with a capacity of 600 million kits annually.
  • Global health professionals from Harvard University lauded the factory as a crucial step towards eradicating malaria and infectious diseases in Africa, reducing reliance on imports and improving accessibility.

A state-of-the-art factory, hailed as Africa's first fully localized Rapid Diagnostic Test (RDT) kit facility, has opened in Nigeria, promising to bolster the continent's fight against infectious diseases. The NASENI-Troment Biotechnologies factory, a multi-million dollar venture, is poised to produce 600 million diagnostic kits per year.

This facility built from ground zero in the last 18 months, focuses on manufacturing of RDTs and in-vitro diagnostic (IVD) products, enabling early detection of major infectious and public health diseases.

โ€” Mr. Selim HaniChief Executive Officer and Co-Founder, NASENT-Troment Biotechnologies, explaining the factory's purpose.

This strategic partnership between the National Agency for Science and Engineering Infrastructure (NASENI) and Troment Nigeria Limited focuses on local production of diagnostic technologies, strengthening Nigeria's healthcare sovereignty. The facility will manufacture RDTs and in-vitro diagnostic (IVD) products under the N-CheckUP brand, enabling early detection of major infectious and public health diseases. Products will include tests for Malaria, Hepatitis B & C, HIV ยฝ, Pregnancy, COVID-19 Antigen, Typhoid, Syphilis, and Blood Glucose.

Global medical professionals, scientists, and policymakers participating in Harvard University's 'Science of Defeating Malaria' initiative visited the factory. They expressed strong commendation for the establishment, viewing it as pivotal to eradicating malaria and other infectious diseases across Nigeria and Africa. The initiative, running from June 7-13, 2026, in Abuja, trains global health experts to eliminate malaria.

It is designed to produce 600 million diagnostic kits per year. It will reduce Nigeriaโ€™s (and West Africa) reliance on imported medical diagnostics while improving accessibility and affordability across the country and the African region.

โ€” Mr. Selim HaniChief Executive Officer and Co-Founder, NASENT-Troment Biotechnologies, detailing the factory's capacity and impact.

"This facility built from ground zero in the last 18 months, focuses on manufacturing of RDTs and in-vitro diagnostic (IVD) products, enabling early detection of major infectious and public health diseases," stated Mr. Selim Hani, Chief Executive Officer and Co-Founder of NASENT-Troment Biotechnologies. He added that the factory will reduce Nigeria's and West Africa's reliance on imported medical diagnostics, improving accessibility and affordability.

This facility is Africaโ€™s first fully localised Rapid Diagnostic Test (RDT) kit factory. From concept to full-scale launch, our end-to-end production process is designed to deliver world-class diagnostic solutions built entirely in Africa, for Africa.

โ€” Dr. Engin NarincTechnical Partner, NASENI-Troment Biotechnologies, highlighting the factory's unique position.

Dr. Engin Narinc, Technical Partner at NASENI-Troment Biotechnologies, emphasized the factory's end-to-end production process, designed to deliver world-class diagnostic solutions "built entirely in Africa, for Africa." Professor Dyann Wirth, a leading malariologist from Harvard University and team lead for the initiative, described the facility as "amazing" and a significant contributor to disease eradication efforts on the continent.

This is an amazing facility that would add value to the eradication of malaria and other public health diseases in Nigeria and the continent.

โ€” Prof. Dyann WirthTeam lead, Science of Defeating Malaria Initiative, Harvard University, USA, commenting on the factory's potential.
DistantNews Editorial

Originally published by ThisDay in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.